Physician profile
Everett J Mason
NPI 1972535235
$14,732.29
in general payments reported to CMS, 2019-2025
7 companies · $39.60 in 2025
The $39.60 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.16 · 2023: $80.19 · 2024: $15K · 2025: $39.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $15K · Food and Beverage: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $14,560.00 |
| Food and Beverage | $159.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $14,560.00 | 2024 | |
| Janssen Pharmaceuticals, INC | $46.16 | 2023 | Xarelto |
| Averitas Pharma INC. | $39.60 | 2025 | Qutenza |
| Becton, Dickinson and Company | $39.34 | 2024 | Venclose Maven Catheter |
| Organogenesis INC. | $17.46 | 2023 | Puraply |
| Cardiva Medical, INC. | $16.57 | 2023 | Cardiva Vascade 6/7f Vcs |
| Smith+Nephew, INC. | $13.16 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Everett Mason listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.